Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

bioAffinity Technologies (BIAF) Consolidated Net Income (2022 - 2025)

Historic Consolidated Net Income for bioAffinity Technologies (BIAF) over the last 4 years, with Q3 2025 value amounting to -$5.1 million.

  • bioAffinity Technologies' Consolidated Net Income fell 15244.82% to -$5.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$14.7 million, marking a year-over-year decrease of 7450.88%. This contributed to the annual value of -$9.0 million for FY2024, which is 1389.47% down from last year.
  • According to the latest figures from Q3 2025, bioAffinity Technologies' Consolidated Net Income is -$5.1 million, which was down 15244.82% from -$4.1 million recorded in Q2 2025.
  • In the past 5 years, bioAffinity Technologies' Consolidated Net Income ranged from a high of -$88052.0 in Q2 2022 and a low of -$5.1 million during Q3 2025
  • In the last 4 years, bioAffinity Technologies' Consolidated Net Income had a median value of -$2.1 million in 2024 and averaged -$2.5 million.
  • The largest annual percentage gain for bioAffinity Technologies' Consolidated Net Income in the last 5 years was 5343.22% (2023), contrasted with its biggest fall of 187630.15% (2023).
  • bioAffinity Technologies' Consolidated Net Income (Quarter) stood at -$1.7 million in 2022, then tumbled by 41.72% to -$2.4 million in 2023, then dropped by 25.02% to -$3.0 million in 2024, then plummeted by 70.25% to -$5.1 million in 2025.
  • Its last three reported values are -$5.1 million in Q3 2025, -$4.1 million for Q2 2025, and -$2.7 million during Q1 2025.